|
Volumn 54, Issue 12, 2013, Pages 2191-2192
|
A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MACROSALB TC 99M;
MICROSPHERE;
RESIN;
YTTRIUM 90;
DIAGNOSTIC AGENT;
ARTIFICIAL EMBOLISM;
CLINICAL PRACTICE;
COLORECTAL LIVER METASTASIS;
DOSIMETRY;
EMBOLIC PARTICLE;
HUMAN;
LETTER;
PRACTICE GUIDELINE;
PREDICTION;
PRIORITY JOURNAL;
RADIATION ABSORPTION;
RADIATION DOSE DISTRIBUTION;
RADIATION HAZARD;
RADIATION SAFETY;
RADIOEMBOLIZATION;
TUMOR VOLUME;
CHEMISTRY;
FEMALE;
LIVER;
MALE;
METABOLISM;
NOTE;
RADIATION EXPOSURE;
DIAGNOSTIC USE;
RADIATION RESPONSE;
EMBOLIZATION, THERAPEUTIC;
FEMALE;
HUMANS;
LIVER;
MALE;
MICROSPHERES;
RESINS, SYNTHETIC;
TECHNETIUM TC 99M AGGREGATED ALBUMIN;
|
EID: 84893428008
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: 10.2967/jnumed.113.128553 Document Type: Letter |
Times cited : (11)
|
References (6)
|